Filtered By:
Specialty: Pharmaceuticals
Condition: Heart Attack

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 165 results found since Jan 2013.

Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine
Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for its investigational anti-thrombotic medicine, vorapaxar, has been accepted for standard review by the U.S. Food and Drug Administration (FDA). Merck is seeking FDA approval of vorapaxar for the secondary prevention of cardiovascular events in patients with a history of heart attack and no history of stroke or transient ischemic attack (TIA). About Mer...
Source: Merck.com - Research and Development News - July 24, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Research and Development News Corporate News Latest News Source Type: news

When Disease Can Bring On Stress Disorder
Post-traumatic stress disorder, or PTSD, most often associated with soldiers returning from the battle front, is increasingly being diagnosed in people with medical conditions from stroke and heart attack to cancer.
Source: WSJ.com: Health - June 24, 2013 Category: Pharmaceuticals Tags: FREE Source Type: news

New drug may reduce tissue damage after a heart attack
A chemical compound has been developed to reduce tissue damage following a heart attack, stroke or major surgery.
Source: Pharmaceutical Technology - May 27, 2013 Category: Pharmaceuticals Source Type: news

Rivaroxaban Gains Approval In Europe For ACS Indication
Rivaroxaban (Xarelto, Bayer) has been approved in Europe for the prevention of atherothrombotic events (cardiovascular death, myocardial infarction or stroke) following an acute coronary syndrome (ACS). The drug was approved at a dose of 2.5 mg twice-daily and should be used in combination with standard antiplatelet therapy. Rivaroxaban is now the only oral anticoagulant to receive an ACS indication.
Source: Forbes.com Healthcare News - May 24, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Bayer’s Xarelto® Approved in the EU for Secondary Prevention after an Acute Coronary Syndrome (for specialized target groups only)
Following an ACS event, one in ten patients will have another major atherothrombotic event (cardiovascular death, myocardial infarction or stroke) within a year / Xarelto 2.5 mg BID in combination with antiplatelet therapy can help prevent athero-thrombotic events by providing more complete protection than antiplatelet therapy alone / Xarelto is approved to protect patients from blood clots across more venous and arterial thromboembolic conditions than any other novel oral anticoagulant
Source: Bayer Company News - May 24, 2013 Category: Pharmaceuticals Source Type: news

New Lawsuit on Granuflo Stroke: Now, AttorneyOne Can Provide Advice
According to court documents, on January25th, 2013 a man filed a lawsuit in Louisiana Eastern District Court alleging he suffered heart attack and stroke following hemodialysis treatment with Granuflo...(PRWeb April 15, 2013)Read the full story at http://www.prweb.com/releases/2013/4/prweb10631314.htm
Source: PRWeb: Medical Pharmaceuticals - April 18, 2013 Category: Pharmaceuticals Source Type: news

This Tasty Diet Can Prevent Heart Attacks And Strokes, Study Says
A large study conducted with funding from the Spanish government appears to have settled an old debate: What should people eat to avoid having a heart attack or stroke? It turns out it may not be how much fat you eat but what kind.
Source: Forbes.com Healthcare News - February 25, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

¡Olé! How the New Spanish Study Should Change Your Diet
Today the New England Journal of Medicine has published a Spanish study comparing two versions of the Mediterranean diet with a low fat diet and the result is important news if you are interested in reducing your risk of heart disease and stroke. They compared a Mediterranean diet that emphasized extra virgin olive oil, a Mediterranean diet that emphasized nuts and a low fat diet. The Mediterranean diets were the big winners; they reduced the risk of the combination of heart attack, stroke or death from cardiovascular causes by about 30%!
Source: Forbes.com Healthcare News - February 25, 2013 Category: Pharmaceuticals Authors: Harlan Krumholz Source Type: news

US Drug Watchdog Now Urges Any Woman Who had A Out Of The Blue Stroke...
The US Drug Watchdog says, “We now fear a young healthy woman would probably never consider the possibility of birth control pills being responsible for a out of the blue heart attack, stroke,...(PRWeb February 22, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10431559.htm
Source: PRWeb: Medical Pharmaceuticals - February 23, 2013 Category: Pharmaceuticals Source Type: news

US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills and...
The US Drug Watchdog is urging women who used the birth control pills called Yaz, Yasmin, or the generic version called Ocella as far back as 2005, and then suffered a heart attack, a stroke, or a...(PRWeb February 07, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10386834.htm
Source: PRWeb: Medical Pharmaceuticals - February 7, 2013 Category: Pharmaceuticals Source Type: news

The US Drug Watchdog Now Urges Young Women Who Suffered a Heart Attack...
The US Drug Watchdog is urging women, who up to ten years ago were taking Yaz, Yasmin, or Ocella birth control pills, and then suffered a out of the blue heart attack, stroke, blood clotting,...(PRWeb January 31, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10360338.htm
Source: PRWeb: Medical Pharmaceuticals - January 31, 2013 Category: Pharmaceuticals Source Type: news

US Drug Watchdog Now Urges First Year Users of the Birth Control Pills...
The US Drug Watchdog is urging women who used the birth control pills called Yaz, Yasmin, or the generic version called Ocella, and then suffered a heart attack, a stroke, or a pulmonary embolism-to...(PRWeb January 29, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10360053.htm
Source: PRWeb: Medical Pharmaceuticals - January 29, 2013 Category: Pharmaceuticals Source Type: news

Snoring: A New Tip-Off To Stroke and Heart Disease
Snoring isn't just annoying, it's a warning sign of artery damage and potential stroke and heart attack, new research says.
Source: Forbes.com Healthcare News - January 29, 2013 Category: Pharmaceuticals Authors: Melanie Haiken Source Type: news

US Drug Watchdog Now Urges All Women To Use Social Media To Focus On...
The US Drug Watchdog is now urging women to use social media, and networking to get the word out about serious medical side effects such as a heart attack, a stroke, or a pulmonary embolism, blood...(PRWeb January 15, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10313913.htm
Source: PRWeb: Medical Pharmaceuticals - January 16, 2013 Category: Pharmaceuticals Source Type: news